Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

7.7%

1 terminated/withdrawn out of 13 trials

Success Rate

91.7%

+5.2% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 11 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (13)

Showing 13 of 13 trials
NCT05322395Not ApplicableRecruiting

Pragmatic Randomised Trial of the ESC 0/1 Versus 0/3 Hour Troponin Pathway

Role: collaborator

NCT03813966Completed

Nasal Swab Home Collection Kit (NSHC Kit) Study

Role: collaborator

NCT02566447Completed

"Solana™ Trichomonas Assay Field Study"

Role: lead

NCT03238274Completed

Sofia 2 Lyme FIA Whole Blood Clinical Study

Role: lead

NCT03417869Completed

QuickVue Influenza A + B Test Field Study

Role: lead

NCT02153008Completed

Strep A FIA Field Study, Sofia

Role: lead

NCT03099018Completed

Comparison of Two Rapid Antigen Detection Tests for the Detection of Group-A Streptococcal Pharyngitis in Children

Role: collaborator

NCT01803113Completed

Sofia hCG FIA Field Study

Role: lead

NCT01441479Completed

Strep A Fluorescent Immunoassay and Analyzer Field Study

Role: lead

NCT01734668Completed

Sofia RSV FIA Field Study

Role: lead

NCT01494792Terminated

Sofia Strep A FIA Field Study

Role: lead

NCT01309568Completed

"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"

Role: lead

NCT00491283Not ApplicableCompleted

QuickVue Influenza A+B Clinical Field Trial

Role: lead

All 13 trials loaded